Concepedia

Thomas Meng

TM

3

Publications

96

Citations

3

H-Index

2005

Active since

Affiliations

Pfizer (Germany)(Current)

Thomas Meng is an author at Pfizer (Germany) specializing in rheumatoid arthritis, rheumatic diseases, and autoimmune disease.

Top concepts

Publications per year

2005–2022

3

Publications

3

Tolerability and short-term effectiveness of hylan G‐F 20 in 4253 patients with osteoarthritis of the knee in clinical practice

F Kemper, Ullricht Gebhardt, Thomas Meng et al. · Current Medical Research and Opinion · 2005 · 70 citations

Effectiveness of Etanercept in Rheumatoid Arthritis: Real-World Data from the German Non-interventional Study ADEQUATE with Focus on Treat-to-Target and Patient-Reported Outcomes

Eugen Feist, Xenofon Baraliakos, Frank Behrens et al. · Rheumatology and Therapy · 2022 · 15 citations · Full text

Etanercept is effective as monotherapy or in combination with methotrexate in rheumatoid arthritis: subanalysis of an observational study

M. Gaubitz, K. H. Göttl, O. Behmer et al. · Clinical Rheumatology · 2017 · 11 citations

, , +10

Rows per page

1–3 of 3